GJL
FENC icon

Gendell Jeffrey L’s Fennec Pharmaceuticals FENC Stock Holding History

Gendell Jeffrey L’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-83,024
Closed -$511K – 106
2026
Q1 		$511K Sell
83,024
-56,535
-41% -$436K 0.01% 100
2025
Q4 		$1.07M Hold
139,559
– – 0.02% 87
2025
Q3 		$1.31M Sell
139,559
-147
-0.1% -$1.27K 0.02% 82
2025
Q2 		$1.16M Sell
139,706
-55,515
-28% -$380K 0.03% 69
2025
Q1 		$1.19M Sell
195,221
-4,054
-2% -$26K 0.05% 66
2024
Q4 		$1.26M Sell
199,275
-32,566
-14% -$167K 0.04% 74
2024
Q3 		$1.16M Sell
231,841
-51,524
-18% -$298K 0.04% 71
2024
Q2 		$1.73M Sell
283,365
-19,113
-6% -$159K 0.06% 77
2024
Q1 		$3.36M Buy
302,478
+20,000
+7% +$201K 0.13% 55
2023
Q4 		$3.17M Sell
282,478
-3,514
-1% -$29.1K 0.17% 48
2023
Q3 		$2.15M Buy
285,992
+2,579
+0.9% +$21K 0.12% 59
2023
Q2 		$2.5M Buy
283,413
+31,127
+12% +$259K 0.19% 39
2023
Q1 		$2.1M Buy
252,286
+99,216
+65% +$920K 0.2% 47
2022
Q4 		$1.47M Buy
+153,070
New +$1.35M 0.13% 47

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Gendell Jeffrey L's FENC Position: Q2 2026 in Review

Gendell Jeffrey L sold out of Fennec Pharmaceuticals (FENC) in Q2 2026, closing a stake of 83,024 shares — an estimated $511K sold.

Gendell Jeffrey L first reported a position in FENC in Q4 2022 and held it in 14 quarters. The position peaked at $3.36M in Q1 2024. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Gendell Jeffrey L reported no remaining Fennec Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Gendell Jeffrey L sold 83,024 Fennec Pharmaceuticals shares in Q2 2026, an estimated $511K.
  • Gendell Jeffrey L first reported a position in Fennec Pharmaceuticals in Q4 2022 and held it in 14 quarters.
  • Gendell Jeffrey L's Fennec Pharmaceuticals position peaked at $3.36M in Q1 2024.
  • 104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Gendell Jeffrey L's 13F filing for Q2 2026, filed 14 Aug 2026.